Novan Therapeutics Obtains $50,000,000 New Funding Round

  • Feed Type
  • Date
    3/31/2015
  • Company Name
    Novan Therapeutics
  • Mailing Address
    4222 Emperor Boulevard Durham, NC 27703 USA
  • Company Description
    Novan uses a licensed nitric oxide technology, developed at the lab of Schoenfisch, to give medical devices an antimicrobial coating, helping to fight bacteria.
  • Website
    http://www.novantherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $50,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The funds secured will support Novan’s efforts to create impactful, first-in-class, nitric oxide-based healthcare solutions in a number of large market indications.
  • M&A Terms
  • Venture Investor
  • Venture Investor

Trending on Xconomy